The Clinical Landscape in 2025

As we enter 2025, the global clinical landscape is continually evolving, driven by a range of factors, including emerging therapies, technological advances, and logistical challenges. The industry is characterised by both opportunities for innovation and challenges that require strategic solutions to deliver clinical success.

Use of technology continues to gain momentum, enhancing patient engagement and streamlining data collection in decentralised and hybrid trials. Integration of advanced technologies such as AI and machine learning (ML) also gathers pace, reshaping clinical trials by reducing trial timelines and improving efficiency.

Yet the proportion of terminated trials has increased, reflecting financial pressures and geopolitical factors. In 2025, the focus will likely remain on enhancing efficiency, ensuring patient engagement, and navigating the complexities of a globalised clinical research environment.

In this report we provide an overview of key trends shaping clinical trials in 2025 using data and analysis from GlobalData’s Intelligence Center. We will also discuss emerging markets, new tech, the burgeoning field of medicinal cannabis, and underline the importance of logistics.

Download: Clinical Trial Landscape 2025

For further information on our services, please contact us.